文献速递精神分裂症与精神病性障碍

SUPER-Finland研究:遗传因素对精神病性障碍病程严重程度与进展的贡献

Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders.
PubMed 文献 · Mol Psychiatry · 2024-04-01

该研究在SUPER-Finland队列的10,403例精神病性障碍患者中,利用多基因评分与数十年全国住院登记数据,发现高精神分裂症多基因评分与从较低 ranked 精神病性障碍向精神分裂症进展相关,且高精神分裂症多基因评分和低教育程度多基因评分均与精神分裂症患者更高的精神科住院负担相关,但对应不同住院模式。

要点

  • 高精神分裂症多基因评分与精神病性障碍向精神分裂症进展相关(OR=1.32)。
  • 在精神分裂症患者中,高精神分裂症多基因评分和低教育程度多基因评分均与住院负担增加相关。
  • 高精神分裂症多基因评分对应更长住院时间,低教育程度多基因评分对应更短但更频繁住院。

核心结论

  • 高精神分裂症多基因评分和低教育程度多基因评分均对精神病性障碍病程发展产生负面影响,但导致不同的病程轨迹。

研究设计与样本

  • 研究基于SUPER-Finland队列,纳入10,403例已基因分型的精神病性障碍个体,结合芬兰全国住院登记数据(1969年起)进行纵向分析。
  • 采用分层模型按临床严重程度对精神病性诊断排序,并使用多基因评分分析遗传因素与病程严重程度及诊断变迁的关联。

主要发现

  • 高精神分裂症多基因评分与从较低 ranked 精神病性障碍向精神分裂症进展相关(OR=1.32 [1.23-1.43],p=1.26e-12)。
  • 高精神分裂症多基因评分 associated 的住院负担增加由更长的单次住院构成,而低教育程度多基因评分 associated 更短但更频繁的住院。
  • 低教育程度多基因评分的负面效应部分通过物质使用障碍介导。

关键数值与推荐

  • 在精神分裂症患者中,高精神分裂症多基因评分与住院负担增加相关(p=1.00e-04)。
  • 在精神分裂症患者中,低教育程度多基因评分与住院负担增加相关(p=4.53e-10)。

临床怎么用

  • 精神分裂症多基因评分可能有助于识别精神病性障碍患者中向精神分裂症进展风险较高的个体。
  • 教育程度多基因评分可能提示精神分裂症患者更频繁住院的风险,物质使用障碍可能是可干预的中介因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Genetic factors contribute to the susceptibility of psychotic disorders, but less is known how they affect psychotic disease-course development. Utilizing polygenic scores (PGSs) in combination with longitudinal healthcare data with decades of follow-up we investigated the contributing genetics to psychotic disease-course severity and diagnostic shifts in the SUPER-Finland study, encompassing 10 403 genotyped individuals with a psychotic disorder. To longitudinally track the study participants' past disease-course severity, we created a psychiatric hospitalization burden metric using the full-coverage and nation-wide Finnish in-hospital registry (data from 1969 and onwards). Using a hierarchical model, ranking the psychotic diagnoses according to clinical severity, we show that high schizophrenia PGS (SZ-PGS) was associated with progression from lower ranked psychotic disorders to schizophrenia (OR = 1.32 [1.23-1.43], p = 1.26e-12). This development manifested already at psychotic illness onset as a higher psychiatric hospitalization burden, the proxy for disease-course severity. In schizophrenia (n = 5 479), both a high SZ-PGS and a low educational attainment PGS (EA-PGS) were associated with increased psychiatric hospitalization burden (p = 1.00e-04 and p = 4.53e-10). The SZ-PGS and the EA-PGS associated with distinct patterns of hospital usage. In individuals with high SZ-PGS, the increased hospitalization burden was composed of longer individual hospital stays, while low EA-PGS associated with shorter but more frequent hospital visits. The negative effect of a low EA-PGS was found to be partly mediated via substance use disorder, a major risk factor for hospitalizations. In conclusion, we show that high SZ-PGS and low EA-PGS both impacted psychotic disease-course development negatively but resulted in different disease-course trajectories.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kämpe A, Suvisaari J, Lähteenvuo M, et al. Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders. Mol Psychiatry. 2024. PMID: 38556557. doi:10.1038/s41380-024-02516-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。